INS and Hypoglycemia: Rapid-acting insulin analogs (insulin lispro, aspart, and glulisine) may then be added as needed because they can rapidly decrease blood glucose levels while carrying a lower risk of postprandial hypoglycemia than regular short–acting insulin (27).